Consensus recommendation on the treatment of malaria in Southeast Asia

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 29, Issue 2, 1998, Pages 355-360

  Looareesuwan, S ^a   Olliaro, P ^b   White, N J ^a   Chongsuphajaisiddhi, T ^a   Sabcharoen, A ^a   Thimasarn, K ^c   Nosten, F ^a   Singhasivanon, P ^a   Supavej, S ^a   Khusmith, S ^a   Wylings, S ^b   Kanyok, T ^b   Walsh, D ^d   Leggat, P A ^e   Doberstyn, E B ^f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e JAMES COOK UNIVERSITY   (Australia)

^f WHO   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

CONFERENCE PAPER; CONSENSUS DEVELOPMENT; HUMAN; MALARIA; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; SOUTHEAST ASIA;

ANTIMALARIALS; ASIA, SOUTHEASTERN; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX;

EID: 0032082863     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Looareesuwan S, Charoenpan P, Ho M, et al. Fatal malaria after an inadequate response to quinine treatment. J Infect Dis 1990; 161: 577-80.
2. Looareesuwan S, Harinasuta T, Chongsuphajaisiddhi T. Drug resistant malaria with special reference to Thailand. Southeast Asian J Trop Med Public Health 1992; 23: 621-34.
3. Looareesuwan S, Kyle DE, Viravan C, et al. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. Am J Trop Med Hyg 1992; 47: 794-9.
4. Looareesuwan S. Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 1994; 88 (Suppl 1): 9-11.
5. Looareesuwan S, Phillips RE, White NJ, et al. Quinine and severe falciparum malaria in late pregnancy. Lancet 1985; 2: 4-8.
6. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 1996; 54: 62-6.
7. Looareesuwan S, Viravan C, Vanijanonta S, et al. A randomised trial of mefloquine, artesunate, and artesunate followed by mefloquine in acute uncomplicated falciparum malaria. Lancet 1992; 339: 821-4.
8. Looareesuwan S, Viravan C, Vanijanonta S, et al. Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine. Southeast Asian J Trop Med Public Health 1993; 24: 230-4.
9. Looareesuwan S, Vanijanonta S, Viravan C, Wilairatana P, Charoenlarp P, Andril M. Randomised trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria. Ann Trop Med Parasitol 1994; 88: 131-6.
10. Looareesuwan S. Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 1994; 88 (Suppl 1): 9-11.
11. Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Pitisuttithum P, Andrial M. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two-and three-day regimens. Am J Trop Med Hyg 1996; 54: 210-3.
12. Looareesuwan S, Wilairatana P, Vanijanonta S, Kyle D, Webster K. Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet 1992; 339: 369.
13. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomised trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1994; 50: 784-9.
14. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 1996; 54: 62-6.
15. Looareesuwan S, Charoenpan P, Ho M, et al. Fatal malaria after an inadequate response to quinine treatment. J Infect Dis 1990; 161: 577-80.
16. Looareesuwan S, Wilairatana P, Vanijanonta S, Viravan C, Andrial M. Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria. Ann Trop Med Parasitol 1995; 89: 469-75.
17. Luxemburger C, ter Kuile F, Nosten F, et al. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1994; 88: 213-7.
18. Luxemburger C, Nosten F, Shotar, Raimond D, Chongsuphajaisiddhi T, White NJ. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am J Trop Med Hyg 1995; 53: 522-5.(Abstract)
19. Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J Trop Med Public Health 1991 ; 22: 380-5.
20. Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1996; 90: 415-7.
21. Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast Asian J Trop Med Public Health 1991; 22: 539-3.
22. Baird JK, Fryauff DJ, Basri H, et al. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg 1995; 52: 479- 84.
23. Brewer TG, Peggins JO, Grate SJ, et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 1994a; 88 (Suppl 1): 33-6.
24. Brewer TG, Grate SJ, Peggins JO, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994; 51: 251-9.
25. Fryauff DJ, Baird JK, Basri H, et al. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995; 346: 1190-3.
26. Nosten F, Luxemburger C, ter Kuile FO, et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis 1994; 170: 971-7.
27. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, et al. Mefloquine-resistant falciparum malaria on the ThaiBurmese border. Lancet 1991; 337: 1140-43.
28. Nosten F, ter Kuile FO, Luxemburger C, et al. Cardiac effects of antimalarial reatment with halofantrine. Lancet 1993; 341: 1054-6.
29. Nosten F. Halofantrine in the treatment of malaria. Drug Safety 1995; 13: 271-2.
30. Price RN, Nosten F, Luxemburger C, et al. Artesunate/ Mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91: 574-7.
31. Price RN, Nosten F, Luxemburger C, et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 523-7.
32. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347: 1654-8.
33. Hien TT, Day NPJ, Phu NH, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335: 76-83.
34. Hien TT, Arnold K, Hung NT, et al. Single dose artemisinin-mefloquine treatment for acute uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1994; 88: 688- 91.
35. Hien TT, Tam DTH, Cue NTK, Arnold K. Comparative effectiveness of artemisinin suppositories and oral quinine in children with acute falciparum malaria. Trans R Soc Trop Med Hyg 1991; 85: 210-1.
36. Hien TT, Arnold K, Vinh H, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria Trans R Soc Trop Med Hyg 1992; 86: 582-3.
37. Karbwang J, Bangchang KN, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet 1992; 340:1245-48.
38. Karbwang J, Na Bangchang K, Thanavibul A, Ditta-in M, Harinasuta T. A comparative clinical trial of two different regimens of artemether plus mefloquine in multidrug resistant malaria. Trans R Soc Trop Med Hyg 1995; 89: 290-8.
39. Karbwang J, Na Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Bull WHO 1994; 72: 233-8.
40. Karbwang J, Na Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Bull WHO 1994; 72: 233-8.
41. McGready R, Cho T, Cho JJ, et al. Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. Am J Trop Med Hyg 1998 (in press).
42. Smithuis FM, van Woensel JB, Nordlander E, Vantha WS, ter Kuile FO. Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob Agents Chemother 1993; 37: 1977-81.
43. ter Kuile FO, Dolan G, Nosten F, et al. Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 1993; 341: 1044-9.
44. ter Kuile F, Nosten F, Thieren M, et al. High dose mefloquine in the treatment of multidrug resistant falciparum malaria. J Infect Dis 1992; 166: 1393-400.
45. ter Kuile FO, Nosten F, Luxemburger C, et al. Mefloquine treatment of acute falciparum malaria: A prospective study of non-serious adverse effects in 3,673 patients. Trans R Soc Trop Med Hyg 1996; 73: 631-42.
46. van Vugt M, Brockman A, Gemperli B, et al. Randomised comparison of artemether-benflumetol and artesunate-mefloquine in the treatment of multidrug resistant falciparum malaria. Antimicrob Agents Chemother 1998; 42: 135-9.
47. Tanariya P, Na Bangchang K, Tin T, Limpaibul L, Brockelman CR, Karbwang J. Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand. Trans R Soc Trop Med Hyg 1995a; 89: 426-9.
48. Tanariya P, Na Bangchang K, Tin T, Limpaibul L, Brockelman CR, Karbwang J. Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand. Trans R Soc Trop Med Hyg 1995b; 89: 426-9.
49. Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994; 88: 324-7.
50. White NJ, Looareesuwan S, Warrell DA, et al. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983, 32: 1-5.
51. White NJ, Warrell DA, Chanthavanich P, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983; 309: 61-6.
52. Murphy SA, Mberu E, Muhia DK, et al. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg 1997; 91: 331-4.
53. Murphy GS, Basri H, Purnomo, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993; 341: 96-100.
54. Hien TT, Tam DTH, Cue NTK, Arnold K. Comparative effectiveness of artemisinin suppositories and oral quinine in children with acute falciparum malaria. Trans R Soc Trop Med Hyg 1991; 85: 210-1.
55. Hien TT, Arnold K, Vinh H, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992; 86: 582-3.